605116 奥锐特
已收盘 02-09 15:00:00
资讯
新帖
简况
2月2日奥锐特跌7.08%，建信高端医疗股票A基金重仓该股
证券之星 · 02-02
2月2日奥锐特跌7.08%，建信高端医疗股票A基金重仓该股
每周股票复盘：奥锐特（605116）董事褚义舟拟减持不超0.98%股份
证券之星 · 02-01
每周股票复盘：奥锐特（605116）董事褚义舟拟减持不超0.98%股份
每周股票复盘：奥锐特（605116）完成6002万股份回购
证券之星 · 01-25
每周股票复盘：奥锐特（605116）完成6002万股份回购
奥锐特（605116）披露股份回购实施结果暨股份变动公告，1月21日股价下跌1.27%
证券之星 · 01-21
奥锐特（605116）披露股份回购实施结果暨股份变动公告，1月21日股价下跌1.27%
股市必读：奥锐特（605116）1月19日收盘跌6.04%，主力净流入2095.54万元
证券之星 · 01-20
股市必读：奥锐特（605116）1月19日收盘跌6.04%，主力净流入2095.54万元
每周股票复盘：奥锐特（605116）回购价上限调至35.00元/股
证券之星 · 01-18
每周股票复盘：奥锐特（605116）回购价上限调至35.00元/股
奥锐特（605116）披露调整回购价格上限，1月12日股价上涨0.36%
证券之星 · 01-12
奥锐特（605116）披露调整回购价格上限，1月12日股价上涨0.36%
每周股票复盘：奥锐特（605116）累计回购2,627,238股
证券之星 · 01-11
每周股票复盘：奥锐特（605116）累计回购2,627,238股
奥锐特涨10.00%，太平洋二个月前给出“买入”评级
证券之星 · 01-08
奥锐特涨10.00%，太平洋二个月前给出“买入”评级
异动快报：奥锐特（605116）1月8日9点39分触及涨停板
证券之星 · 01-08
异动快报：奥锐特（605116）1月8日9点39分触及涨停板
每周股票复盘：奥锐特（605116）拟注销1.2万股限制性股票
证券之星 · 01-02
每周股票复盘：奥锐特（605116）拟注销1.2万股限制性股票
每周股票复盘：奥锐特（605116）股东减持100万股 占总股本0.25%
证券之星 · 2025-12-28
每周股票复盘：奥锐特（605116）股东减持100万股 占总股本0.25%
12月24日奥锐特发布公告，股东减持100万股
证券之星 · 2025-12-24
12月24日奥锐特发布公告，股东减持100万股
奥锐特（605116）披露通过药品GMP符合性检查，12月18日股价上涨0.59%
证券之星 · 2025-12-18
奥锐特（605116）披露通过药品GMP符合性检查，12月18日股价上涨0.59%
奥锐特(605116.SH)通过药品GMP符合性检查
智通财经 · 2025-12-18
奥锐特(605116.SH)通过药品GMP符合性检查
奥锐特（605116）披露以集中竞价交易方式回购公司股份的进展公告，12月01日股价上涨1.06%
证券之星 · 2025-12-01
奥锐特（605116）披露以集中竞价交易方式回购公司股份的进展公告，12月01日股价上涨1.06%
奥锐特：11月24日高管赵珍平减持股份合计10000股
证券之星 · 2025-11-25
奥锐特：11月24日高管赵珍平减持股份合计10000股
奥锐特(605116.SH)子公司获雌二醇片/雌二醇地屈孕酮片复合包装注册批件
智通财经 · 2025-11-25
奥锐特(605116.SH)子公司获雌二醇片/雌二醇地屈孕酮片复合包装注册批件
每周股票复盘：奥锐特（605116）回购股份2,224,738股用于转债转换
证券之星 · 2025-11-23
每周股票复盘：奥锐特（605116）回购股份2,224,738股用于转债转换
每周股票复盘：奥锐特（605116）高管赵珍平两日减持合计2.57万股
证券之星 · 2025-11-16
每周股票复盘：奥锐特（605116）高管赵珍平两日减持合计2.57万股
加载更多
公司概况
公司名称：
奥锐特药业股份有限公司
所属行业：
医药制造业
上市日期：
2020-09-21
主营业务：
奥锐特药业股份有限公司的主营业务是特色复杂原料药、医药中间体和制剂的研发、生产和销售。公司的主要产品是呼吸系统、心血管、抗感染、神经系统、抗肿瘤和女性健康类产品。
发行价格：
8.37
{"stockData":{"symbol":"605116","market":"SH","secType":"STK","nameCN":"奥锐特","latestPrice":27.12,"timestamp":1770620400000,"preClose":27.61,"halted":0,"volume":4970028,"delay":0,"changeRate":-0.0177,"floatShares":405999999,"shares":405999999,"eps":1.0452,"marketStatus":"已收盘","change":-0.49,"latestTime":"02-09 15:00:00","open":27.6,"high":27.88,"low":26.99,"amount":135000000,"amplitude":0.0322,"askPrice":27.14,"askSize":10,"bidPrice":27.12,"bidSize":109,"shortable":0,"etf":0,"ttmEps":1.0452,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770687000000},"marketStatusCode":5,"adr":0,"adjPreClose":27.61,"symbolType":"stock","openAndCloseTimeList":[[1770600600000,1770607800000],[1770613200000,1770620400000]],"highLimit":30.37,"lowLimit":24.85,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":406183234,"isCdr":false,"pbRate":4.37,"roa":"--","peRate":25.947187,"roe":"14.37%","epsLYR":0.89,"committee":0.615023,"marketValue":11016000000,"turnoverRate":0.0122,"status":1,"floatMarketCap":11016000000},"requestUrl":"/m/hq/s/605116","defaultTab":"news","newsList":[{"id":"2608085130","title":"2月2日奥锐特跌7.08%，建信高端医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608085130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608085130?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:39","pubTimestamp":1770021566,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日奥锐特跌7.08%，收盘报26.66元，换手率1.68%，成交量6.81万手，成交额1.86亿元。重仓奥锐特的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为建信基金的建信高端医疗股票A。该公募基金现任基金经理为马牧青。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159891","605116"],"gpt_icon":0},{"id":"2608070541","title":"每周股票复盘：奥锐特（605116）董事褚义舟拟减持不超0.98%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608070541","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608070541?lang=zh_cn&edition=full","pubTime":"2026-02-01 04:11","pubTimestamp":1769890270,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，奥锐特报收于28.69元，较上周的31.29元下跌8.31%。本周，奥锐特1月26日盘中最高价报31.27元。本周关注点公司公告汇总：董事褚义舟因个人资金需求，计划减持不超过公司总股本的0.98%。公司公告汇总奥锐特药业股份有限公司董事褚义舟持有公司股份112,294,800股，占总股本的27.65%，股份来源为IPO前取得。因个人资金需求，褚义舟计划自公告发布之日起15个交易日后3个月内，通过集中竞价方式减持不超过400万股，即不超过公司总股本的0.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2606237506","title":"每周股票复盘：奥锐特（605116）完成6002万股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2606237506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606237506?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:35","pubTimestamp":1769283311,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，奥锐特报收于31.29元，较上周的34.43元下跌9.12%。本周，奥锐特1月19日盘中最高价报35.58元，股价触及近一年最高点。本次回购股份资金总额不低于6,000万元且不高于12,000万元，回购股份用于转换公司可转债。回购完成后，公司总股本由406,195,000股变更为406,183,234股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2605548341","title":"奥锐特（605116）披露股份回购实施结果暨股份变动公告，1月21日股价下跌1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605548341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605548341?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:37","pubTimestamp":1769006230,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，奥锐特报收于31.15元，较前一交易日下跌1.27%，最新总市值为126.53亿元。公告称，公司于2025年1月21日至2026年1月20日实施股份回购，累计回购股份2,778,338股，占公司总股本的0.68%，实际回购金额为60,028,504.68元，回购价格区间为18.83元/股至33.00元/股。本次回购股份资金总额不低于6,000万元且不高于12,000万元，回购股份用于转换公司可转债。回购完成后，公司总股本由406,195,000股变更为406,183,234股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100041194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2604213026","title":"股市必读：奥锐特（605116）1月19日收盘跌6.04%，主力净流入2095.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604213026","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604213026?lang=zh_cn&edition=full","pubTime":"2026-01-20 02:25","pubTimestamp":1768847109,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，奥锐特报收于32.35元，下跌6.04%，换手率2.34%，成交量9.49万手，成交额3.16亿元。当日关注点来自交易信息汇总：奥锐特1月19日收盘报32.35元，跌6.04%，主力资金当日净流入443.56万元。来自交易信息汇总：前10个交易日主力资金累计净流入1404.62万元，期间股价累计上涨23.3%。该股最近90天内共有2家机构给出评级，买入评级2家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000000929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2604923305","title":"每周股票复盘：奥锐特（605116）回购价上限调至35.00元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604923305","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604923305?lang=zh_cn&edition=full","pubTime":"2026-01-18 02:30","pubTimestamp":1768674629,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，奥锐特报收于34.43元，较上周的30.69元上涨12.19%。本周，奥锐特1月16日盘中最高价报34.8元，股价触及近一年最高点。1月13日盘中最低价报29.7元。奥锐特当前最新总市值139.85亿元，在化学制药板块市值排名39/150，在两市A股市值排名1497/5183。本次调整无需提交股东大会审议。截至公告日，公司已累计回购股份2,627,238股，占总股本的0.65%，支付资金总额55,124,396.68元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2602354699","title":"奥锐特（605116）披露调整回购价格上限，1月12日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602354699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602354699?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:31","pubTimestamp":1768228272,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，奥锐特报收于30.8元，较前一交易日上涨0.36%，最新总市值为125.1亿元。该股当日开盘30.89元，最高32.15元，最低29.89元，成交额达4.38亿元，换手率为3.47%。公司近日发布公告称，奥锐特药业股份有限公司于2026年1月12日召开第三届董事会第十八次会议，审议通过《关于调整回购股份价格上限的议案》，将回购股份价格上限由不超过24.71元/股调整为不超过35.00元/股，回购方案其他内容不变。本次调整无需提交股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200037459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2602330895","title":"每周股票复盘：奥锐特（605116）累计回购2,627,238股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602330895","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602330895?lang=zh_cn&edition=full","pubTime":"2026-01-11 02:19","pubTimestamp":1768069147,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，奥锐特报收于30.69元，较上周的25.05元上涨22.51%。本周关注点公司公告汇总：奥锐特累计回购2,627,238股，占总股本0.65%。本次回购用于转换公司可转债，回购期限为2025年1月21日至2026年1月20日，预计回购金额为6,000万元至12,000万元。奥锐特药业股份有限公司关于可转债转股结果暨股份变动公告截至2025年12月31日，累计已有面值9,000元“奥锐转债”转为公司A股普通股，累计转股353股，占转股前总股本的0.0001%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2601356863","title":"奥锐特涨10.00%，太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601356863","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601356863?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:33","pubTimestamp":1767857621,"startTime":"0","endTime":"0","summary":"今日奥锐特涨10.00%，收盘报28.27元。2025年11月1日，太平洋研究员周豫,乔露阳发布了对奥锐特的研报《Q3利润快速增长，多肽及小核酸加速放量》，该研报对奥锐特给出“买入”评级。研报中预测公司2025/26/27年营收为17.18/19.74/22.05亿元，归母净利润为4.61/5.92/7.10亿元，对应2025/26/27年PE为20/16/13X，持续给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为71.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800019155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","605116"],"gpt_icon":0},{"id":"2601355813","title":"异动快报：奥锐特（605116）1月8日9点39分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601355813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601355813?lang=zh_cn&edition=full","pubTime":"2026-01-08 09:40","pubTimestamp":1767836455,"startTime":"0","endTime":"0","summary":"证券之星1月8日盘中消息，9点39分奥锐特触及涨停板。其所属行业化学制药目前上涨。领涨股为必贝特。该股为量子计算，化学原料药，医药概念热股，当日量子计算概念上涨1.88%，化学原料药概念上涨0.91%，医药概念上涨0.78%。1月7日的资金流向数据方面，主力资金净流出1808.71万元，占总成交额18.58%，游资资金净流入885.39万元，占总成交额9.09%，散户资金净流入923.32万元，占总成交额9.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800008160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2600368770","title":"每周股票复盘：奥锐特（605116）拟注销1.2万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2600368770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600368770?lang=zh_cn&edition=full","pubTime":"2026-01-02 02:36","pubTimestamp":1767292571,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，奥锐特报收于24.45元，较上周的22.25元上涨9.89%。本周，奥锐特12月26日盘中最高价报24.69元。本周关注点公司公告汇总：奥锐特拟注销1名离职激励对象持有的12,000股限制性股票，回购价格为10.33元/股加利息。奥锐特药业股份有限公司因本次回购注销12,000股限制性股票，占公司总股本比例较小，根据可转债转股价格调整公式计算，“奥锐转债”转股价格不作调整，仍为24.94元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2594346247","title":"每周股票复盘：奥锐特（605116）股东减持100万股 占总股本0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594346247","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594346247?lang=zh_cn&edition=full","pubTime":"2025-12-28 04:55","pubTimestamp":1766868908,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，奥锐特报收于24.45元，较上周的22.25元上涨9.89%。本周关注点股本股东变化：股东天台铂恩减持100.0万股，占公司总股本的0.2462%。股本股东变化股东增减持12月24日奥锐特发布公告，股东天台铂恩投资管理合伙企业于2025年12月15日至12月23日间合计减持100.0万股，占公司目前总股本的0.2462%，变动期间该股股价上涨4.44%，截至12月23日收盘报23.03元。本次减持计划已实施完毕，减持后天台铂恩持有公司股份5,606,000股，占总股本1.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2593347552","title":"12月24日奥锐特发布公告，股东减持100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593347552","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593347552?lang=zh_cn&edition=full","pubTime":"2025-12-24 17:45","pubTimestamp":1766569545,"startTime":"0","endTime":"0","summary":"证券之星消息，12月24日奥锐特发布公告《奥锐特:奥锐特药业股份有限公司股东减持股份结果公告》，其股东天台铂恩投资管理合伙企业(有限合伙)于2025年12月15日至2025年12月23日间合计减持100.0万股，占公司目前总股本的0.2462%，变动期间该股股价上涨4.44%，截止12月23日收盘报23.03元。股东增减持详情见下表：根据奥锐特2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400028703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2592902615","title":"奥锐特（605116）披露通过药品GMP符合性检查，12月18日股价上涨0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592902615","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592902615?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:36","pubTimestamp":1766068583,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘，奥锐特报收于22.08元，较前一交易日上涨0.59%，最新总市值为89.69亿元。近日，奥锐特药业股份有限公司发布关于通过药品GMP符合性检查的公告。公告称，公司收到浙江省药品监督管理局签发的《药品GMP符合性检查告知书》，公司位于浙江省天台县八都工业园区的806、863车间A3生产线和802车间BETB生产线通过药品GMP符合性检查，检查时间为2025年11月12日至11月14日，结论为符合《药品生产质量管理规范》及相关法规要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800039164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2592197644","title":"奥锐特(605116.SH)通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2592197644","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592197644?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:52","pubTimestamp":1766047930,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥锐特(605116.SH)发布公告，近日，公司收到浙江省药品监督管理局签发的《药品GMP符合性检查告知书》(浙2025第0267号、浙2025第0268号)，检查范围及相关车间、生产线：1.原料药(糠酸莫米松)：806、863车间，A3生产线;2.原料药(倍他米松)：802车间，BETB生产线。公司本次通过药品GMP符合性检查，表明公司相关生产线符合GMP要求，将有利于公司继续保持稳定的产品质量和持续稳定的生产能力，以满足相关药品的市场需求。本次获得药品GMP符合性检查结果不会对公司业绩产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2588775073","title":"奥锐特（605116）披露以集中竞价交易方式回购公司股份的进展公告，12月01日股价上涨1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588775073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588775073?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:35","pubTimestamp":1764599711,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，奥锐特报收于22.89元，较前一交易日上涨1.06%，最新总市值为92.98亿元。近日，奥锐特药业股份有限公司发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，截至2025年11月30日，公司通过集中竞价交易方式累计回购股份2,350,238股，占公司总股本的0.58%，已支付资金总额48,999,398.68元，回购价格区间为18.83元/股至22.59元/股。本次回购股份用于转换公司可转债，回购期限为2025年1月21日至2026年1月20日，资金总额预计6,000万元至12,000万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100037228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2586420535","title":"奥锐特：11月24日高管赵珍平减持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586420535","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586420535?lang=zh_cn&edition=full","pubTime":"2025-11-25 20:02","pubTimestamp":1764072162,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月25日市场公开信息、上市公司公告及交易所披露数据整理，奥锐特（605116）最新董监高及相关人员股份变动情况：2025年11月24日公司高级管理人员赵珍平共减持公司股份1.0万股，占公司总股本为0.0025%。变动期间公司股价上涨0.0%，11月24日当日收盘报21.99元。奥锐特近半年内的董监高及核心技术人员增减持详情如下：奥锐特的高管列表及最新持股情况如下：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500034265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2586473994","title":"奥锐特(605116.SH)子公司获雌二醇片/雌二醇地屈孕酮片复合包装注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2586473994","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586473994?lang=zh_cn&edition=full","pubTime":"2025-11-25 15:36","pubTimestamp":1764056205,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥锐特(605116.SH)发布公告，近日，公司全资子公司扬州奥锐特药业有限公司(简称“扬州奥锐特”)收到国家药品监督管理局核准签发的一份雌二醇片/雌二醇地屈孕酮片复合包装《药品注册证书》。该药品用于治疗自然或术后绝经所致的围绝经期综合征。本次扬州奥锐特的雌二醇片/雌二醇地屈孕酮片复合包装(注册商标“奥舒桐”)按照化学药品新注册分类方法获得药品注册批件，有利于提升公司在该药品领域的市场竞争力，同时新批准产品在国内上市销售，有望对公司经营业绩产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"奥锐特(605116.SH)子公司获雌二醇片/雌二醇地屈孕酮片复合包装注册批件","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2585105544","title":"每周股票复盘：奥锐特（605116）回购股份2,224,738股用于转债转换","url":"https://stock-news.laohu8.com/highlight/detail?id=2585105544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585105544?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:27","pubTimestamp":1763839631,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，奥锐特报收于21.99元，较上周的23.52元下跌6.51%。本周，奥锐特11月17日盘中最高价报23.9元。本周关注点公司公告汇总：奥锐特药业股份有限公司累计回购股份2,224,738股，占总股本0.55%。公司公告汇总奥锐特药业股份有限公司自2025年11月1日至11月21日，通过集中竞价交易方式累计回购股份2,224,738股，占公司总股本的0.55%，回购价格区间为18.83元/股至22.59元/股，支付资金总额46,231,070.68元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2583544136","title":"每周股票复盘：奥锐特（605116）高管赵珍平两日减持合计2.57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583544136","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583544136?lang=zh_cn&edition=full","pubTime":"2025-11-16 05:05","pubTimestamp":1763240715,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，奥锐特报收于23.52元，较上周的22.84元上涨2.98%。本周，奥锐特11月14日盘中最高价报23.8元。本周关注点股本股东变化：高管赵珍平两日合计减持2.57万股，占总股本0.0063%。股本股东变化高管增减持2025年11月12日，公司高级管理人员赵珍平减持2.0万股，占公司总股本0.0049%，当日收盘价23.34元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770665427885,"stockEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":-0.1163},{"period":"3month","weight":0.1869},{"period":"6month","weight":0.1472},{"period":"1year","weight":0.3489},{"period":"ytd","weight":0.0826}],"compareEarnings":[{"period":"1week","weight":0.0267},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0301},{"period":"6month","weight":0.1194},{"period":"1year","weight":0.248},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"奥锐特药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11515人(较上一季度减少2.17%)","perCapita":"35274股","listingDate":"2020-09-21","address":"浙江省台州市天台县八都工业园区","registeredCapital":"40618万元","survey":" 奥锐特药业股份有限公司的主营业务是特色复杂原料药、医药中间体和制剂的研发、生产和销售。公司的主要产品是呼吸系统、心血管、抗感染、神经系统、抗肿瘤和女性健康类产品。","listedPrice":8.37},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥锐特(605116)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥锐特,605116,奥锐特股票,奥锐特股票老虎,奥锐特股票老虎国际,奥锐特行情,奥锐特股票行情,奥锐特股价,奥锐特股市,奥锐特股票价格,奥锐特股票交易,奥锐特股票购买,奥锐特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥锐特(605116)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}